NAMS
NewAmsterdam Pharma Company N.V.
$34.91
-$0.16(-0.46%)
52
Overall
--
Value
90
Tech
15
Quality
Market Cap
$3.90B
Volume
405.29K
52W Range
$14.06 - $42.00
Target Price
$49.92
EPS Estimates Overview
| Current Quarter | $-0.46 | Next Quarter | $-0.48 |
| Current Year | $-1.89 | Next Year | $-1.15 |
| QoQ Growth | -4.3% | YoY Growth | +39.2% |
| 3Y EPS CAGR | -63.3% | Target Price | $49.92 |
| Consensus | Buy | Upside | +43.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $34.91 | -0.5% | 405.29K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW